Sat 19 Jul 2008
2008 is turning to be a year of consolidation in the global pharma industry. The world leader in generic drugs - Teva has bought out Barr Labs for over $7.4 billion. Read this NYT story.
But, its not being so easy for others. According to latest reports Czech generic medicine maker Zentiva’s Board has appealed to its shareholders to reject the share purchase offer from French brand drug maker Sanofi, the price being too low. Watch this development carefully.
It could be an indirect invite for more compelling bids from other companies.